222 related articles for article (PubMed ID: 38639944)
1. Modelling the micro- and macro- environment of pancreatic cancer: from patients to pre-clinical models and back.
Lloyd EG; Henríquez JA; Biffi G
Dis Model Mech; 2024 Apr; 17(4):. PubMed ID: 38639944
[TBL] [Abstract][Full Text] [Related]
2. Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models.
Heinrich MA; Mostafa AMRH; Morton JP; Hawinkels LJAC; Prakash J
Adv Drug Deliv Rev; 2021 Jul; 174():265-293. PubMed ID: 33895214
[TBL] [Abstract][Full Text] [Related]
3. Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma.
Sharma GG; Okada Y; Von Hoff D; Goel A
Semin Cancer Biol; 2021 Oct; 75():153-168. PubMed ID: 33049362
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue.
Longo V; Brunetti O; Gnoni A; Cascinu S; Gasparini G; Lorusso V; Ribatti D; Silvestris N
Oncotarget; 2016 Sep; 7(36):58649-58658. PubMed ID: 27462915
[TBL] [Abstract][Full Text] [Related]
5. A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma.
Drifka CR; Eliceiri KW; Weber SM; Kao WJ
Lab Chip; 2013 Oct; 13(19):3965-75. PubMed ID: 23959166
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.
Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M
Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602
[TBL] [Abstract][Full Text] [Related]
7. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
8. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma.
Han Y; Drobisch P; Krüger A; William D; Grützmann K; Böthig L; Polster H; Seifert L; Seifert AM; Distler M; Pecqueux M; Riediger C; Plodeck V; Nebelung H; Weber GF; Pilarsky C; Kahlert U; Hinz U; Roth S; Hackert T; Weitz J; Wong FC; Kahlert C
J Hematol Oncol; 2023 Feb; 16(1):7. PubMed ID: 36737824
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer.
Zhang D; Li L; Jiang H; Li Q; Wang-Gillam A; Yu J; Head R; Liu J; Ruzinova MB; Lim KH
Cancer Res; 2018 Apr; 78(7):1700-1712. PubMed ID: 29363544
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma.
Askan G; Sahin IH; Chou JF; Yavas A; Capanu M; Iacobuzio-Donahue CA; Basturk O; O'Reilly EM
BMC Cancer; 2021 Apr; 21(1):385. PubMed ID: 33836674
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment.
Tarannum M; Vivero-Escoto JL
Adv Drug Deliv Rev; 2022 Aug; 187():114357. PubMed ID: 35605679
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
[TBL] [Abstract][Full Text] [Related]
13. Update on the management of pancreatic cancer: surgery is not enough.
Ansari D; Gustafsson A; Andersson R
World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
[TBL] [Abstract][Full Text] [Related]
14. Impacting Pancreatic Cancer Therapy in Heterotypic
Obaid G; Bano S; Mallidi S; Broekgaarden M; Kuriakose J; Silber Z; Bulin AL; Wang Y; Mai Z; Jin W; Simeone D; Hasan T
Nano Lett; 2019 Nov; 19(11):7573-7587. PubMed ID: 31518145
[TBL] [Abstract][Full Text] [Related]
15. Viscoelastic properties of human pancreatic tumors and in vitro constructs to mimic mechanical properties.
Rubiano A; Delitto D; Han S; Gerber M; Galitz C; Trevino J; Thomas RM; Hughes SJ; Simmons CS
Acta Biomater; 2018 Feb; 67():331-340. PubMed ID: 29191507
[TBL] [Abstract][Full Text] [Related]
16. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.
Novák Š; Kolář M; Szabó A; Vernerová Z; Lacina L; Strnad H; Šáchová J; Hradilová M; Havránek J; Španko M; Čoma M; Urban L; Kaňuchová M; Melegová N; Gürlich R; Dvořák J; Smetana K; Gál P; Szabo P
Cancer Genomics Proteomics; 2021; 18(3):221-243. PubMed ID: 33893076
[TBL] [Abstract][Full Text] [Related]
17. Genetics and biology of pancreatic ductal adenocarcinoma.
Hezel AF; Kimmelman AC; Stanger BZ; Bardeesy N; Depinho RA
Genes Dev; 2006 May; 20(10):1218-49. PubMed ID: 16702400
[TBL] [Abstract][Full Text] [Related]
18. Orthotopic Models of Pancreatic Cancer to Study PDT.
Obaid G; Mai Z; Hasan T
Methods Mol Biol; 2022; 2451():163-173. PubMed ID: 35505017
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
[TBL] [Abstract][Full Text] [Related]
20. Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options.
Kabacaoglu D; Ciecielski KJ; Ruess DA; Algül H
Front Immunol; 2018; 9():1878. PubMed ID: 30158932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]